| Literature DB >> 21552259 |
Panagiotis Prinos1, Daniel Garneau, Jean-François Lucier, Daniel Gendron, Sonia Couture, Marianne Boivin, Jean-Philippe Brosseau, Elvy Lapointe, Philippe Thibault, Mathieu Durand, Karine Tremblay, Julien Gervais-Bird, Hanad Nwilati, Roscoe Klinck, Benoit Chabot, Jean-Pierre Perreault, Raymund J Wellinger, Sherif Abou Elela.
Abstract
Most human genes produce multiple mRNA isoforms through alternative splicing. However, the biological relevance of most splice variants remains unclear. In this study, we evaluated the functional impact of alternative splicing in cancer cells. We modulated the splicing pattern of 41 cancer-associated splicing events and scored the effects on cell growth, viability and apoptosis, identifying three isoforms essential for cell survival. Specifically, changing the splicing pattern of the spleen tyrosine kinase gene (SYK) impaired cell-cycle progression and anchorage-independent growth. Notably, exposure of cancer cells to epithelial growth factor modulated the SYK splicing pattern to promote the pro-survival isoform that is associated with cancer tissues in vivo. The data suggest that splicing of selected genes is specifically modified during tumor development to allow the expression of isoforms that promote cancer cell survival.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21552259 DOI: 10.1038/nsmb.2040
Source DB: PubMed Journal: Nat Struct Mol Biol ISSN: 1545-9985 Impact factor: 15.369